Cell and gene therapy companies develop advanced treatments that modify, replace or engineer cells and genetic material to treat disease. The field is one of the fastest-growing areas of biotechnology and precision medicine.
This category includes companies working on:
Browse 144 UK cell and gene therapy companies below.
Contract development and manufacture of nanofibrous biomaterials for medical devices
The Electrospinning Company designs, develops, and manufactures nanofibrous biomaterials for implantable medical devices and regenerative medicine applications. Using…
Global biologics CDMO for vaccines, antibodies, and advanced therapies
FUJIFILM Biotechnologies is a contract development and manufacturing organisation providing process development and cGMP manufacturing of biologics, vaccines, and cell and gene…
AI bioprocess operating system for cell and gene therapy manufacturing
Native Labs Ltd is a software company developing an AI-powered bioprocess operating system for cell and gene therapy manufacturing. The platform unifies heterogeneous…
Stem cell-derived exosome platform for targeted drug delivery
ReNeuron is a biotechnology company developing a stem cell-derived exosome platform for targeted therapeutic delivery. Founded on over two decades of stem cell science, including…
In vivo cell reprogramming therapies for degenerative disease
Mogrify is a biotechnology company developing a novel class of in vivo reprogramming therapies for degenerative diseases. Its proprietary platforms use large-scale transcriptomic…
Single-use bioprocess solutions supplier for life sciences
BioPharma Dynamics is a supplier of single-use bioprocess solutions for the life sciences and pharmaceutical industries. The company sources products from multiple market-leading…
Global CDMO for drug development, delivery and manufacture
Catalent Pharma Solutions is a contract development and manufacturing organisation providing drug development, formulation, and manufacturing services across small molecules,…
Long-lasting RNA platform for cell engineering and therapy manufacture
Plurify is a biotech developing a long-lasting RNA platform that enables stable, non-integrating gene expression in cells for over 100 days without genomic integration. The system…
Hypoxia-activated CAR-T cell therapy platform for solid tumour cancers
Korecyte Bio is a preclinical-stage cell therapy company developing HypoxiCAR, a modular CAR-T platform for treating solid tumours. The technology uses a dual-sensor genetic…
Next-generation viral vectors engineered for safer gene therapy delivery
Sandbox Bioscience is a biotechnology company developing next-generation viral delivery vectors for gene therapy. Founded by a team of virologists with extensive experience in…
Oncolytic virus platform for tumour-targeted cancer immunotherapy
Accession Therapeutics is a clinical-stage biotechnology company developing tumour-targeted immunotherapies based on its proprietary oncolytic virus platform. Designed for…
Clinical-stage developer of oncolytic immunotherapies for cancer treatment
Replimune is the UK research and development site of Replimune Group, a clinical-stage biotechnology company developing oncolytic immunotherapies for cancer. Its platform uses…